EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The gut microbiota and colorectal cancer: Molecular insights and translational implications

Jinmiao Chen, Xiuqi Du, Minke Shao, Yifan Sun, Xinyu Shi, Songbing He

Clinical Surgical Oncology · 2025-12 · 4 (4) · 100107

DOI: 10.1016/j.cson.2025.100107 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Surgical Oncology, 2025-12. Verfasst von Jinmiao Chen und 5 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Soochow University, Suzhou City Science and Technology Bureau.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, the gut microbiota have identified as a modifiable key environmental factor influencing the development and progression of colorectal cancer (CRC). Molecular epidemiological studies, including cross-sectional and prospective cohort designs, have consistently identified distinct microbial dysbiosis in CRC patients, characterized by an enrichment of pro-inflammatory and genotoxin-producing bacteria, alongside a reduction in protective commensals. Mendelian randomization analyses further support a causal role for specific microbial taxa in CRC pathogenesis. Mechanistically, gut microbes contribute to tumorigenesis through direct genotoxic effects (e.g., DNA damage), activation of inflammatory pathways, and metabolite-mediated interactions—exhibiting dual roles, as seen with short-chain fatty acids versus secondary bile acids. These processes often interact with host genetic backgrounds, forming complex gene-environment interactions. These findings the potential of microbiota-derived signatures as biomarkers for early detection and prognostic prediction. Furthermore, microbiota-targeted strategies—such as dietary interventions, probiotics, pharmaceuticals, and nanotechnology-based approaches—are being actively explored for precision prevention and treatment of CRC. • Gut microbiota dysbiosis causally linked to colorectal cancer risk. • Microbes drive CRC via genotoxicity, inflammation, and metabolite signaling. • Microbial signatures enable early detection and prognosis prediction. • Microbiota-targeted strategies show promise for precision CRC prevention. • Multi-omics reveal novel microbiome-based biomarkers and therapies.

Förderung

  • Soochow University
  • Suzhou City Science and Technology Bureau

Zitieren

APA

Chen, J., Du, X., Shao, M., Sun, Y., Shi, X., & He, S. (2025). The gut microbiota and colorectal cancer: Molecular insights and translational implications. Clinical Surgical Oncology, 4(4), 100107. https://doi.org/10.1016/j.cson.2025.100107

Vancouver

Chen J, Du X, Shao M, Sun Y, Shi X, He S. The gut microbiota and colorectal cancer: Molecular insights and translational implications. Clinical Surgical Oncology. 2025;4(4):100107. doi:10.1016/j.cson.2025.100107

BibTeX
@article{Chen2025,
  author = {Chen, Jinmiao and Du, Xiuqi and Shao, Minke and Sun, Yifan and Shi, Xinyu and He, Songbing},
  title = {The gut microbiota and colorectal cancer: Molecular insights and translational implications},
  journal = {Clinical Surgical Oncology},
  year = {2025},
  volume = {4},
  number = {4},
  pages = {100107},
  doi = {10.1016/j.cson.2025.100107}
}
Kostenlos starten →